Literature DB >> 3436367

Effects of intracoronary propranolol on coronary blood flow and regional myocardial function in dogs.

K Noguchi1, R Sunagawa, T Kato, F Nagamine, M Sakanashi.   

Abstract

The study was conducted to evaluate the effects of intracoronary administration of dl-propranolol on coronary blood flow and regional myocardial function in anesthetized open-chest dogs. The results were compared with those obtained with d-propranolol, atenolol and lidocaine. Bolus intracoronary injections of dl-propranolol (0.02-2 mg) dose dependently produced transient increases in coronary blood flow and subsequent depression in regional segment shortening which qualitatively resembled those produced by the dextro isomer (0.02-2 mg) and lidocaine (0.2-10 mg). Atenolol (up to 2 mg) was almost devoid of these effects. Isoproterenol-induced responses were abolished by dl-propranolol and atenolol but only incompletely blocked by d-propranolol. These results demonstrate that propranolol at high doses has direct coronary vasodilating and cardiodepressant effects in situ, and indicate that the major part of these effects can be attributed to the membrane-stabilizing action rather than beta-adrenoceptor blockade.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436367     DOI: 10.1016/0014-2999(87)90520-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

Review 1.  Pharmacology of acute effort angina.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

2.  Pharmacological evidence of α2-adrenergic receptors in the hypotensive effect of Platonia insignis mart.

Authors:  Marcelo Bezerra Mendes; José Couras da Silva-Filho; Carla Kelly Barroso Sabino; Daniel Dias Rufino Arcanjo; Cleyton Marcos Melo Sousa; Isabella Cristhina Gonçalves Costa; Mariana Helena Chaves; Rita de Cássia Meneses Oliveira; Aldeídia P Oliveira
Journal:  J Med Food       Date:  2014-07-23       Impact factor: 2.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.